Feyti Medical Group offers an AI-driven platform that streamlines clinical trials, regulatory compliance, and pharmacovigilance for pharmaceutical companies
To every father and father figure, thank you for your sacrifices and the powerful example you set. Wishing you a joyful and well-deserved Father’s Day! 💙
#father#fathersday
🎉 Happy Birthday to our Director at Feyti Medical Group @amon_nyesigye!
Thank you for your outstanding leadership and unwavering commitment to advancing healthcare innovation across Africa.
Wishing you a wonderful year ahead!
#FeytiMedicalGroup#Leadership#HappyBirthday
To all our healthcare heroes: Thank you for your courage, compassion, and sacrifice every single day. Feyti Medical Group stands with you, empowering safer medicine through technology and expertise. Happy Heroes Day! ✨ #Feyti#HeroesDay
🚀Reflex AI(May24): Autonomous PV agent swarm by @rsusny
Polls OpenFDA every 60s, 11 AI agents analyze recalls, ranks substitutes, auto-generates memos. Cuts manual pharmacy phone check delays for FDA recalls. Built in 5.5hrs!
https://t.co/essdCAyP91
#AgenticAI#Pharmacovigilance
Introducing Reflex AI: the world’s first autonomous pharmacovigilance agent swarm where AI agents pay other AI agents for verified drug safety analysis.
Built in 5.5 hours at the Agentic Engineering Hack hosted by tokens& at Datadog NYC HQ.
FDA issues ~2,000 drug recalls/year. Hospitals still rely on pharmacy phone tag before identifying affected patients. People keep refilling contaminated lots.
Reflex changes that:
• Polls OpenFDA every 60s
• 11 specialized AI agents run in parallel
• Counter-evidence agent hunts manufacturer rebuttals before publish
• ESM2-650M protein embeddings rank substitute drugs by molecular similarity
• Auto-generates pharmacist memos, clinician alerts & patient letters with full audit logs
#AgenticAI #Pharmacovigilance #HealthTech
End of retroactive clinical trials? 🚀 FDA launched real-time trials with @AstraZeneca & @Amgen ;live safety signals to regulators.
AI-powered pilot RFI open until May 29.
#AIcyclinder is built for this future of real-time PV.
The shift is here.
Thoughts?👇https://t.co/fMokBhORKO
🤝 Feyti x UIRI: Future-Proofing Industry 🚀
We met with Prof. Charles Kwesiga, ED of @UIRI_Ug, to discuss the 4th Industrial Revolution.
The focus: using AI and automation to scale local industrial development. The future of Uganda is smart & tech-driven! 🇺🇬💡
#4IR#AI#Feyti
🚀 Feyti at National Science Week 2026! 🇺🇬 Showcased Aicyclinder, our AI-driven compliance platform, at Kololo. From smart healthcare systems to engaging with investors, the energy was clear: STI is the engine for Uganda’s future.
Turn innovation into impact! 💡⚙️ #STI#AI#Feyti
Big News! 🇺🇬
NDA just launched IRIMS, fully online regulatory system. No more paper files or queues. Real-time tracking, error checks & one account for everything.
Licenses, product registration, imports, PV reports, all digital now.
#Uganda#IRIMS#NDA#RegulatoryAffairs
Happy Labour Day!
Today, we celebrate the dedication& passion that drive every worker forward.
Thank you to all professionals who show up, serve, and make a difference every single day. Your work matters.
#LabourDay#Feyti#Celebrate
🌍PV ALERT: The 2026 Pharmacovigilance Mandate is active.
The industry has officially crossed the threshold from "pilot" monitoring to real-time safety governance. Are you are not audit-ready or behind?
A summary of the 2026 shifts:
#Pv#DrugSafety#feyti#RegulatoryCompliance 👇
2025 Phase 2a (Nature Medicine): safe, well-tolerated, promising lung improvement.
2026: larger trials planned + inhaled version explored.
This could speed up drug discovery & help patients faster.
Excited about AI drugs?
https://t.co/GXc9lyQGpG
#AIDrugDiscovery#Biotech
What if AI could invent a new medicine from scratch?
It happened.
Insilico’s Rentosertib;first fully AI-discovered & AI-designed drug & reached clinical proof-of-concept for IPF (serious lung-scarring disease).
https://t.co/MnicdAR63d found TNIK target & designed it in ~18 month
This brings higher quality, consistent data across submissions,
stronger analytics for faster signal detection,
and true global ICH harmonization.
Accelerate migration if you're still on E2B(R2)
Federal Register (Apr6,2026):
https://t.co/qkFLNgA9RZ 👇
#PV#RegulatoryAffairs#AEMS
🚨 FDA E2B(R3) Update for PV & Reg Affairs
Post-marketing ICSRs must switch to ICH E2B(R3) format starting Oct 1, 2026.
FDA stops accepting legacy E2B(R2) after Sept 30, 2026 (via ESG NextGen for drugs, biologics & combos).
#Pharmacovigilance#DrugSafety#FDA#E2BR3
This #Easter, Feyti Medical Group wishes the #Christian community a blessed season of #hope and #renewal.
May you embrace new beginnings, good health, and peace. 🤍
Key benefits:
• Stronger oversight against counterfeits
• Tougher penalties for fake medicines& misleading ads
• Better emergency access & global alignment
Clearer rules for the entire medical supply chain.
Full story:
https://t.co/y7K86wHMUU
Your thoughts?👇
#Health#Uganda
Uganda’s health sector enters a new era🚨
Parliament just passed the National Drug and Health Products Authority Bill, 2025 at Third Reading.
It replaces the old NDA with the new NDHPA, now regulating drugs, medical devices, cosmetics, supplements, diagnostics& vaccines.
#NDHPA